IART Q3 2017 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q3 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$279M+11.4% YoY

Gross Profit

$177M63.5% margin

Operating Income

$11M3.8% margin

Net Income

$3M1.1% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

-1.2%

Cash Flow

Operating Cash Flow

$45M

Free Cash Flow

$37M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.5B

Stockholders' Equity

$913M

Cash & Equivalents

$482M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$279M	$250M	+11.4%
Gross Profit	$177M	$161M	+10.0%
Operating Income	$11M	$30M	-64.6%
Net Income	$3M	$20M	-84.3%

Revenue Segments

Specialty Surgical Solutions

$165M59%

Orthopedics and Tissue Technologies

$114M41%

Geographic Segments

UNITED STATES

$214M77%

Europe

$33M12%

Rest Of World

$33M12%